AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

Statement: NIH Discontinues Immunizations in HIV Vaccine Study

NIAID

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will stop administering injections in its HVTN 505 clinical trial of an investigational HIV vaccine regimen because an independent data and safety monitoring board (DSMB) found during a scheduled interim review that the vaccine regimen did not prevent HIV infection nor…

New NIH Award Aims to Reduce Asian American Hepatitis B Disparities through Health Information Technology

Ronald Valdiserri

A new grant award by the National Institute on Minority Health and Health Disparities (NIMHD) will support the development of new Health Information Technology (HIT) strategies that increase screening for chronic hepatitis B and reduce the impact of hepatitis B among high-risk Asian American and Pacific Islander (AAPI) populations.  Hepatitis B virus (HBV) infection is…

Conversations from CROI 2013: HRSA’s Dr. Laura Cheever

Cheever CROI 2013

In the final episode in my series of conversations from the 2013 Conference on Retroviruses and Opportunistic Infections (CROI) (held in Atlanta earlier this month), I had the opportunity to talk with Dr. Laura Cheever, HRSA’s Acting Associate Administrator for the HIV/AIDS Bureau. At CROI, she and her colleagues shared a new analysis of the…

Addressing the Needs of Individuals Coinfected with HIV and TB

Ronald Valdiserri

This weekend, we observe World Tuberculosis (TB) Day (Sunday, March 24), a day to remember that the global burden of TB remains enormous, particularly among people with HIV/AIDS, among whom TB is the leading cause of death, worldwide. According to the World Health Organization  (WHO), in 2011, 1.4 million people died from TB, including 430,000…

Conversations from CROI 2013: CDC’s Dr. Jonathan Mermin

Mermin Croi 2013

During the 2013 Conference on Retroviruses and Opportunistic Infections  (CROI) in Atlanta earlier this month, I had the opportunity to sit down with Dr. Jonathan Mermin, Director of CDC’s Division of HIV/AIDS Prevention. We discussed some of the important research findings being shared at the conference and their implications for our efforts to respond effectively…

Conversations from CROI 2013: CDC’s Dr. John Ward

Dr. John Ward

Viral hepatitis was among the topics receiving significant attention at the 2013 Conference on Retroviruses and Opportunistic Infections  (CROI) in Atlanta this week. Sessions and posters explored a spectrum of topics ranging from virology to new frontiers in hepatitis treatments as well as examinations of HIV/HCV coinfection and its treatment. Following his conference address, “Expanding…

HRSA HIV/AIDS Bureau Releases Preliminary Data on the Continuum of HIV Care among Ryan White Clients at CROI 2013

HRSA logo

New data shows that the majority of patients receiving medical care funded by the Federal Ryan White HIV/AIDS Program (RW) are virally suppressed. The Health Resources and Services Administration’s (HRSA) HIV/AIDS Bureau (HAB) presented the data on the continuum of HIV care in the Ryan White HIV/AIDS Program at the 20th Conference on Retroviruses and…

Prevention and Treatment of HIV Infection in Infants Born to Infected Mothers: Need for a Fresh Look

dieffenbachfauci2

On Monday, March 4, 2013, at the Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta, Dr. Deborah Persaud of the Johns Hopkins University presented an intriguing case study of a child who by all measures seems to be cured of HIV infection. This single case has sparked significant conversation, debate, and optimism. This blog…